- Home
- EVEX vs CNTA Comparison
EVEX vs CNTA Comparison
Compare EVEX & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVEX
- CNTA
- Stock Information
- Founded
- EVEX 2020
- CNTA 2020
- Country
- EVEX United States
- CNTA United Kingdom
- Employees
- EVEX N/A
- CNTA N/A
- Industry
- EVEX Aerospace
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- EVEX Industrials
- CNTA Health Care
- Exchange
- EVEX Nasdaq
- CNTA Nasdaq
- Market Cap
- EVEX 2.2B
- CNTA 1.9B
- IPO Year
- EVEX N/A
- CNTA 2021
- Fundamental
- Price
- EVEX $6.43
- CNTA $16.17
- Analyst Decision
- EVEX Strong Buy
- CNTA Strong Buy
- Analyst Count
- EVEX 3
- CNTA 11
- Target Price
- EVEX $6.67
- CNTA $28.90
- AVG Volume (30 Days)
- EVEX 542.0K
- CNTA 950.8K
- Earning Date
- EVEX 08-05-2025
- CNTA 08-12-2025
- Dividend Yield
- EVEX N/A
- CNTA N/A
- EPS Growth
- EVEX N/A
- CNTA N/A
- EPS
- EVEX N/A
- CNTA N/A
- Revenue
- EVEX N/A
- CNTA $15,000,000.00
- Revenue This Year
- EVEX N/A
- CNTA N/A
- Revenue Next Year
- EVEX N/A
- CNTA N/A
- P/E Ratio
- EVEX N/A
- CNTA N/A
- Revenue Growth
- EVEX N/A
- CNTA 118.88
- 52 Week Low
- EVEX $2.33
- CNTA $9.00
- 52 Week High
- EVEX $7.70
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- EVEX 49.60
- CNTA 71.07
- Support Level
- EVEX $6.27
- CNTA $13.22
- Resistance Level
- EVEX $7.48
- CNTA $16.15
- Average True Range (ATR)
- EVEX 0.49
- CNTA 0.67
- MACD
- EVEX -0.14
- CNTA 0.20
- Stochastic Oscillator
- EVEX 11.55
- CNTA 98.18
About EVEX Eve Holding Inc.
Eve Holding Inc is a provider of Urban Air Mobility solutions. The company's operating segments are; eVTOL that includes; the design and production of electric vertical take-off and landing vehicles (eVTOLs) including fixed wing and helicopter operators, as well as lessors that purchase and manage aircraft on behalf of operators; Service and Operations Solutions segment which includes a portfolio of maintenance and support services focused on its and third-party eVTOLs; and the UATM segment , a new Urban Air Traffic Management system designed to allow eVTOLs to operate safely and efficiently in dense urban airspace alongside conventional aircraft and drones.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.